Anterix (ATEX) Current Deferred Revenue (2014 - 2025)

Anterix has reported Current Deferred Revenue for 12 years, with the latest figure at $7.9 million in Q4 2025.

• For the quarter ending Q4 2025, Current Deferred Revenue fell 93.76% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (down 93.76% YoY), and the FY2025 full-year result was $6.1 million, down 95.01% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $7.9 million, down from $130.4 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $130.4 million in Q3 2025, with the low at $737000.0 in Q2 2021.
• Historically, Current Deferred Revenue has averaged $55.1 million across 5 years, with a median of $54.3 million in 2022.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 7219.54% — and 2025, when it plunged 95.01%.
• Anterix's Current Deferred Revenue stood at $1.5 million in 2021, then soared by 441.27% to $8.0 million in 2022, then decreased by 13.75% to $6.9 million in 2023, then jumped by 1726.97% to $126.1 million in 2024, then sank by 93.76% to $7.9 million in 2025.
• The last three Current Deferred Revenue figures came in at $7.9 million (Q4 2025), $130.4 million (Q3 2025), and $128.2 million (Q2 2025), per Business Quant data.